Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Deferred Taxes (2016 - 2018)

Apyx Medical's Deferred Taxes history spans 7 years, with the latest figure at $736000.0 for Q4 2018.

  • For Q4 2018, Deferred Taxes rose 275.51% year-over-year to $736000.0; the TTM value through Dec 2019 reached $932000.0, up 5.67%, while the annual FY2018 figure was $368000.0, 87.76% up from the prior year.
  • Deferred Taxes reached $736000.0 in Q4 2018 per APYX's latest filing, up from $196000.0 in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $5.9 million in Q4 2014 to a low of -$1.3 million in Q3 2014.
  • Average Deferred Taxes over 4 years is $605375.0, with a median of $10000.0 recorded in 2014.
  • The largest YoY upside for Deferred Taxes was 1192.01% in 2014 against a maximum downside of 109.74% in 2014.
  • A 4-year view of Deferred Taxes shows it stood at $5.9 million in 2014, then crashed by 100.85% to -$50000.0 in 2016, then skyrocketed by 492.0% to $196000.0 in 2017, then skyrocketed by 275.51% to $736000.0 in 2018.
  • Per Business Quant, the three most recent readings for APYX's Deferred Taxes are $736000.0 (Q4 2018), $196000.0 (Q4 2017), and -$50000.0 (Q4 2016).